July 18, 2022 Clinical Research/Diagn. Product Launch Roche launches innovative dual antigen and antibody diagnostic test supporting the fight to eliminate the hepatitis C virus Read more
July 14, 2022 Uncategorized Eight-year data from APHINITY study show Roche’s Perjeta-based regimen continues to reduce the risk of disease returning for people with HER2-positive early breast cancer Read more
July 14, 2022 Product Launch New two-year data confirm Roche’s Vabysmo improves vision with fewer treatments for people with neovascular age-related macular degeneration Read more
July 11, 2022 Bio/Pharma/CRO Product Launch New data from phase III HAVEN 6 study reinforce favourable safety and efficacy profile of Roche’s Hemlibra in people with moderate or mild haemophilia A Read more
July 6, 2022 Acad, Gov/Utilities FDA grants Priority Review to Roche’s Lunsumio for people with relapsed or refractory follicular lymphoma Read more
June 29, 2022 Clinical Research/Diagn. Microscopy Product Launch Roche launches new BenchMark ULTRA PLUS system for cancer diagnostics enabling timely, targeted patient care Read more
June 28, 2022 Clinical Research/Diagn. Product Launch Roche launches the VENTANA DP 600 slide scanner for digital pathology, enhancing patient care with precision diagnostics Read more
June 16, 2022 Product Launch Roche launches human papillomavirus (HPV) self-sampling solution, expanding cervical cancer screening options Read more
June 16, 2022 Uncategorized Roche provides update on Alzheimer’s Prevention Initiative study evaluating crenezumab in autosomal dominant Alzheimer’s disease Read more
June 15, 2022 Acad, Gov/Utilities Life Science Tools PR/Corporate Roche receives FDA EUA for cobas SARS-CoV-2 Duo, the first PCR test to simultaneously detect COVID-19 and quantitatively measure viral load levels of COVID-19 Read more
